Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Califf Suggests Congress ‘Tighten Up Laws’ To Address Orange Book Abuses

Apr 12 2024

• By Sarah Karlin-Smith

FDA Commissioner Robert Califf — FDA Commissioner Robert Califf testified at the House Oversight Committee on 11 April. • Source: Screenshot

Related Content

In Swift Challenge To Orange Book Patent Listings, Federal Trade Commission Fills FDA Ministerial Gap

Nov 08 2023

FTC/Industry Showdown Over Orange Book Patent Listings Could Come In 2024

Jan 05 2024

FDA “Ministerial” Approach To Patent Listings Upheld By Appeals Court

Nov 03 2003

Payors Take Lead From FTC In Suing BI Over Its Orange Book Patent Listings For Inhalers

Mar 13 2024

Orange Book Policing May Increase, US FDA's Gottlieb Says

Jan 10 2019

Possible Orange Book Revisions Back In Play With US FDA Report To Congress

Feb 24 2022

Additional Topics

United States Intellectual Property Generic Drugs Policy Politics Pricing Debate BioPharmaceutical

More from Legal & IP

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window